Hutchison China MediTech Ltd ADR buy Bank of America Co.
Start price
22.07.25
/
50%
€14.60
Target price
22.07.26
€23.95
Performance (%)
-15.75%
Price
09.01.26
€12.50
Summary
This prediction is currently active. The price of Hutchison China MediTech Ltd ADR has decreased since the start of the prediction. Compared to the start price this results in a performance of -15.75%. This prediction currently runs until 22.07.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Hutchison China MediTech Ltd ADR | 9.649% | 9.649% |
| iShares Core DAX® | 2.331% | 5.140% |
| iShares Nasdaq 100 | 2.077% | 2.956% |
| iShares Nikkei 225® | 2.759% | 7.214% |
| iShares S&P 500 | 1.613% | 2.893% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Hutchison China MediTech Ltd ADR diskutieren
HUTCHMED (China) Limited Sponsored ADR (NASDAQ: HCM) had its price target raised by analysts at Bank of America Corporation from $27.00 to $28.00. They now have a "buy" rating on the stock.
Ratings data for HCM provided by MarketBeat

